128 related articles for article (PubMed ID: 9873172)
1. Oxidative stress in Adamantiades-Behçet's disease.
Freitas JP; Filipe P; Yousefi A; Emerit I; Guerra Rodrigo F
Dermatology; 1998; 197(4):343-8. PubMed ID: 9873172
[TBL] [Abstract][Full Text] [Related]
2. Clastogenic factors in plasma of HIV-1 infected patients.
Fuchs J; Emerit I; Levy A; Cernajvski L; Schöfer H; Milbradt R
Free Radic Biol Med; 1995 Dec; 19(6):843-8. PubMed ID: 8582657
[TBL] [Abstract][Full Text] [Related]
3. Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's disease.
Chekaoui A; Lahmar K; Belguendouz H; Mazari F; Terahi M; Hakem D; Youinou P; Touil-Boukoffa C
Eur Cytokine Netw; 2018 Sep; 29(3):95-102. PubMed ID: 30547891
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serum nitric oxide, malondialdehyde levels, and antioxidant enzyme activities in Behçet's disease with and without ocular disease.
Aydin E; Sögüt S; Ozyurt H; Ozugurlu F; Akyol O
Ophthalmic Res; 2004; 36(3):177-82. PubMed ID: 15103210
[TBL] [Abstract][Full Text] [Related]
5. Clastogenic activity in the plasma of scleroderma patients: a biomarker of oxidative stress.
Emerit I; Filipe P; Meunier P; Auclair C; Freitas J; Deroussent A; Gouyette A; Fernandes A
Dermatology; 1997; 194(2):140-6. PubMed ID: 9094462
[TBL] [Abstract][Full Text] [Related]
6. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
7. Lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
Sandikci R; Türkmen S; Güvenen G; Ayabakan H; Gülcan P; Koldas M; Ozbek Kir Z; Yenice N
Acta Derm Venereol; 2003; 83(5):342-6. PubMed ID: 14609100
[TBL] [Abstract][Full Text] [Related]
8. Familial Mediterranean fever: clastogenic plasma factors correlated with increased O2(-)--production by neutrophils.
Sarkisian T; Emerit I; Arutyunyan R; Levy A; Cernjavski L; Filipe P
Hum Genet; 1997 Dec; 101(2):238-42. PubMed ID: 9402978
[TBL] [Abstract][Full Text] [Related]
9. Oxidative stress in patients with Behcet's disease: I correlation with severity and clinical parameters.
Najim RA; Sharquie KE; Abu-Raghif AR
J Dermatol; 2007 May; 34(5):308-14. PubMed ID: 17408439
[TBL] [Abstract][Full Text] [Related]
10. Lipid peroxidation and homocysteine levels in Behçet's disease.
Mungan AG; Can M; Açikgöz S; Eştürk E; Altinyazar C
Clin Chem Lab Med; 2006; 44(9):1115-8. PubMed ID: 16958606
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
Evereklioglu C; Er H; Türköz Y; Cekmen M
Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide, lipid peroxidation and antioxidant defence system in patients with active or inactive Behçet's disease.
Buldanlioglu S; Turkmen S; Ayabakan HB; Yenice N; Vardar M; Dogan S; Mercan E
Br J Dermatol; 2005 Sep; 153(3):526-30. PubMed ID: 16120137
[TBL] [Abstract][Full Text] [Related]
13. Vitamin levels in Behçet's disease.
Kandi B; Cicek D; Ilhan N
J Dermatolog Treat; 2007; 18(2):69-75. PubMed ID: 17520462
[TBL] [Abstract][Full Text] [Related]
14. The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behçet's disease.
Köse K; Yazici C; Aşşioğlu O
Clin Biochem; 2001 Mar; 34(2):125-9. PubMed ID: 11311222
[TBL] [Abstract][Full Text] [Related]
15. In vitro antioxidant effect of Ginkgo biloba extract (EGb 761) on lipoperoxidation induced by hydrogen peroxide in erythrocytes of Behçet's patients.
Köse K; Doğan P; Aşçioğlu M; Aşçioğlu O
Jpn J Pharmacol; 1997 Nov; 75(3):253-8. PubMed ID: 9434256
[TBL] [Abstract][Full Text] [Related]
16. Serum oxidant/antioxidant status in patients with Behçet's disease.
Taysi S; Kocer I; Memisogullari R; Kiziltunc A
Ann Clin Lab Sci; 2002; 32(4):377-82. PubMed ID: 12458889
[TBL] [Abstract][Full Text] [Related]
17. Oxyradical-mediated clastogenic plasma factors in psoriasis: increase in clastogenic activity after PUVA.
Filipe P; Emerit I; Alaoui Youssefi A; Levy A; Cernjavski L; Freitas J; de Castro JL
Photochem Photobiol; 1997 Oct; 66(4):497-501. PubMed ID: 9337621
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil and lymphocyte responses to oral Streptococcus in Adamantiades-Behçet's disease.
Kurauchi T; Yokota K; Matsuo T; Fujinami Y; Isogai E; Isogai H; Ohtsuki H; Oguma K
FEMS Immunol Med Microbiol; 2005 Feb; 43(2):125-31. PubMed ID: 15681141
[TBL] [Abstract][Full Text] [Related]
19. The serum vitamin C levels in Behçet's disease.
Noyan T; Sahin I; Sekeroğlu MR; Dülger H
Yonsei Med J; 2003 Oct; 44(5):771-8. PubMed ID: 14584091
[TBL] [Abstract][Full Text] [Related]
20. Incidence, prevalence, and mortality of Adamantiades-Behçet's disease in Korea: a nationwide, population-based study (2006-2015).
Lee YB; Lee SY; Choi JY; Lee JH; Chae HS; Kim JW; Han KD; Park YG; Yu DS
J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):999-1003. PubMed ID: 28940547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
